ACT Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History

ACT Capital Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.08M	Sell	60,000 -5,000	-8%	-$79.8K	1.49%	17
2022 Q2	$808K	Sell	65,000 -20,000	-24%	-$221K	1.13%	21
2022 Q1	$1.13M	Hold	85,000	–	–	1.2%	22
2021 Q4	$1.32M	Hold	85,000	–	–	0.96%	25
2021 Q3	$1.91M	Sell	85,000 -2,500	-3%	-$54.9K	0.99%	23
2021 Q2	$1.99M	Buy	+87,500	New	+$1.84M	1.02%	24

Other funds holding MYOV

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ACT Capital Management's MYOV Position: Q3 2022 in Review

ACT Capital Management reduced its Myovant Sciences Ltd. (MYOV) stake by 7.7% in Q3 2022, selling an estimated $79.8K and leaving 60,000 shares worth $1.08M. The position accounts for 1.49% of the portfolio, ranked #17.

ACT Capital Management first reported a position in MYOV in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.99M in Q2 2021. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

ACT Capital Management held 60,000 shares of Myovant Sciences Ltd. worth $1.08M as of Q3 2022.
ACT Capital Management sold 5,000 Myovant Sciences Ltd. shares in Q3 2022, an estimated $79.8K.
Myovant Sciences Ltd. made up 1.49% of ACT Capital Management's portfolio in Q3 2022, its #17 holding.
ACT Capital Management first reported a position in Myovant Sciences Ltd. in Q2 2021 and has held it in 6 quarters since.
ACT Capital Management's Myovant Sciences Ltd. position peaked at $1.99M in Q2 2021.
98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.